CHARACTERIZATION OF HUMANIZED ANTI-P185HER2 ANTIBODY FAB FRAGMENTS PRODUCED IN ESCHERICHIA-COLI

被引:0
|
作者
KELLEY, RF
OCONNELL, MP
CARTER, P
PRESTA, L
EIGENBROT, C
COVARRUBIAS, M
SNEDECOR, B
SPECKART, R
BLANK, G
VETTERLEIN, D
KOTTS, C
机构
[1] GENENTECH INC, DEPT FERMENTAT, San Francisco, CA 94080 USA
[2] GENENTECH INC, DEPT PROC SCI, San Francisco, CA 94080 USA
[3] GENENTECH INC, DEPT MED & ANALYT CHEM, San Francisco, CA 94080 USA
来源
ACS SYMPOSIUM SERIES | 1993年 / 526卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We have been using biochemical and biophysical methods to characterize chimeric and humanized variants of the murine monoclonal antibody 4D5, directed against human epidermal growth factor receptor 2 (p185HER2). These studies were performed on antibody Fab fragments produced by secretion from E. coli. Humanized Fab fragment (hu4D5-8 Fab) was expressed at very high levels (1-2 g/L), whereas chimeric Fab (ch4D5 Fab) was expressed at much lower titers (5-20 mg/L), as determined by antigen-binding ELISA of supernatants from 10 L fermentations. Hu4D5-8 Fab and ch4D5 Fab purified by using affinity chromatography on immobilized bacterial IgG-binding proteins gave identical far UV-CD spectra characteristic of the immunoglobulin fold. Thermodynamic studies of antigen binding show comparable affinities (DELTAG) for ch and hu4D5-8 Fab, but different DELTAH values suggesting slight differences in the mechanism of binding. This difference is reflected in the anti-proliferative activity of these fragments on human breast tumor cells.
引用
收藏
页码:218 / 239
页数:22
相关论文
共 50 条
  • [41] RECOMBINANT COLORIMETRIC ANTIBODIES - CONSTRUCTION AND CHARACTERIZATION OF A BIFUNCTIONAL F(AB)2/ALKALINE PHOSPHATASE CONJUGATE PRODUCED IN ESCHERICHIA-COLI
    DUCANCEL, F
    GILLET, D
    CARRIER, A
    LAJEUNESSE, E
    MENEZ, A
    BOULAIN, JC
    BIO-TECHNOLOGY, 1993, 11 (05): : 601 - 605
  • [42] Evaluation of an anti-p185HER2 (scFv-CH2-CH3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK
    Vaidyanathan, Ganesan
    Jestin, Emmanuelle
    Olafsen, Tove
    Wu, Anna M.
    Zalutsky, Michael R.
    NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (06) : 671 - 680
  • [43] 2-PHASE APPROACH FOR THE EXPRESSION OF HIGH-AFFINITY HUMAN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS IMMUNOGLOBULIN FAB DOMAINS IN ESCHERICHIA-COLI
    TAKEDA, S
    DORFMAN, NA
    ROBERTGUROFF, M
    NOTKINS, AL
    RANDO, RF
    HYBRIDOMA, 1995, 14 (01): : 9 - 18
  • [44] Characterization of engineered anti-pI85HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting
    Olafsen, T
    Tan, GJ
    Cheung, CW
    Yazaki, PJ
    Park, JM
    Shively, JE
    Williams, LE
    Raubitschek, AA
    Press, MF
    Wu, AM
    PROTEIN ENGINEERING DESIGN & SELECTION, 2004, 17 (04): : 315 - 323
  • [45] ISOLATION AND PARTIAL CHARACTERIZATION OF 2 DIFFERENT HEAT-STABLE ENTEROTOXINS PRODUCED BY BOVINE AND PORCINE STRAINS OF ENTEROTOXIGENIC ESCHERICHIA-COLI
    KAPITANY, RA
    FORSYTH, GW
    SCOOT, A
    MCKENZIE, SF
    WORTHINGTON, RW
    INFECTION AND IMMUNITY, 1979, 26 (01) : 173 - 177
  • [46] PROTEIN ENGINEERING OF ANTIBODY-BINDING SITES - RECOVERY OF SPECIFIC ACTIVITY IN AN ANTI-DIGOXIN SINGLE-CHAIN FV ANALOG PRODUCED IN ESCHERICHIA-COLI
    HUSTON, JS
    LEVINSON, D
    MUDGETTHUNTER, M
    TAI, MS
    NOVOTNY, J
    MARGOLIES, MN
    RIDGE, RJ
    BRUCCOLERI, RE
    HABER, E
    CREA, R
    OPPERMANN, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) : 5879 - 5883
  • [47] EXPRESSION OF CYTOCHROME-P450 2D6 IN ESCHERICHIA-COLI, PURIFICATION, AND SPECTRAL AND CATALYTIC CHARACTERIZATION
    GILLAM, EMJ
    GUO, ZY
    MARTIN, MV
    JENKINS, CM
    GUENGERICH, FP
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 319 (02) : 540 - 550
  • [48] P-FIMBRIAE OF ESCHERICHIA-COLI - IMMUNOCHEMICAL AND PROTEIN-CHEMICAL CHARACTERIZATION OF FIMBRIAE FROM 2 PYELONEPHRITOGENIC STRAINS
    RHEN, M
    KLEMM, P
    WAHLSTROM, E
    SVENSON, SB
    KALLENIUS, G
    KORHONEN, TK
    FEMS MICROBIOLOGY LETTERS, 1983, 18 (03) : 233 - 238
  • [49] Effects of variable domain orientation on anti-HER2 single-chain variable fragment antibody expressed in the Escherichia coli cytoplasm
    Kocer, Ilkay
    Cox, Emily C.
    DeLisa, Matthew P.
    Celik, Eda
    BIOTECHNOLOGY PROGRESS, 2021, 37 (02)
  • [50] DEVELOPMENT OF A HUMANIZED DISULFIDE-STABILIZED ANTI-BETA-P185(HER2) FV-BETA-LACTAMASE FUSION PROTEIN FOR ACTIVATION OF A CEPHALOSPORIN DOXORUBICIN PRODRUG
    RODRIGUES, ML
    PRESTA, LG
    KOTTS, CE
    WIRTH, C
    MORDENTI, J
    OSAKA, G
    WONG, WLT
    NUIJENS, A
    BLACKBURN, B
    CARTER, P
    CANCER RESEARCH, 1995, 55 (01) : 63 - 70